HUM-MOLGEN events: Longitudinal Qualitative Research: A Powerful Tool for Patient-centred Research

Who Should Attend?

This webinar will be particularly useful for cross-functional teams involved in clinical research, including executives, directors and project leaders from pharma and biotech involved in clinical research protocol development and clinical research conduct. Specific roles include:

Research and development

Clinical operations

Clinical science

Outcomes researchers

Regulatory

Pharmacovigilance

Medical affairs

Clinical trial planning and optimization

Outsourcing and procurement

What You Will Learn

Webinar attendees will learn:

The why, when, what and how of qualitative longitudinal research

The design of baseline and follow-up interview guides

The different types of qualitative longitudinal analysis

How to think critically about change over time, including considerations about the quantification of qualitative longitudinal change

The do’s and don’ts on communicating qualitative longitudinal results

Speakers

Sally Lanar, Senior Outcomes Researcher, PCO, GHEORE

Sally has over six years of experience in patient-centered outcomes. Her expertise is in longitudinal qualitative research, qualitative research embedded in clinical trials, and the use of qualitative analysis software. She has worked on six projects with longitudinal interviews embedded in clinical trials. For each project, she has developed tailored approaches to interview guide development, interview conduct and interview analysis. She has conducted longitudinal interviews herself and led interview teams and analysis teams in this field.

Message Presenter

Alexia Marrel, Lead Outcomes Researcher, PCO, GHEORE

Alexia has over 15 years of experience, with significant expertise in the management of international projects in the field of patient-centered outcomes. At ICON, she is responsible for the direction of PRO projects and proposals, with specialized interest in qualitative research, specifically in patient interviews within clinical trials, also known as mixed methods research. This work covers a wide range of disease areas, including several rare diseases. Alexia has also co-authored a number of manuscripts published in peer-reviewed journals, as well as delivered presentations at international scientific conferences.